BSE filing, NSE: POONAWALLA. Summary written from the filing by ALFA Finder's alert engine.
Poonawalla Fincorp Ltd: key numbers
- Share price
- ₹403.25
- Market cap
- ₹35,510 Cr
- Revenue (annual)
- ₹6,790 Cr
- Net profit (annual)
- ₹541.8 Cr
- P/E (TTM)
- 32.6×Sector 19.7×
- Promoter holding
- 59.01%-0.01% QoQ
- FII holding
- 11.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Poonawalla Fincorp Ltd
All →Poonawalla Fincorp Debt & Borrowing: ₹2,000 Cr
Poonawalla Fincorp approved ₹2,000 Crore secured NCD issuance via private placement in two series. Debentures carry first-ranking pari passu charge and will be listed on BSE.
- Value
- ₹2,000 Cr
Poonawalla Fincorp Annual General Meeting
Poonawalla Fincorp Ltd issued a postal ballot notice seeking shareholder approval for the re-appointment of Ms. Kemisha Soni as an Independent Director for a second term.
Poonawalla Fincorp Debt & Borrowing
Poonawalla Fincorp confirmed the timely redemption of Commercial Paper maturing on October 16, 2026. This filing fulfills regulatory reporting requirements for debt obligations.
Poonawalla Fincorp Management Change
Poonawalla Fincorp Limited has re-appointed Ms. Kemisha Soni as a Non-Executive Independent Director for a 36-month term, effective October 9, 2026.
Poonawalla Fincorp Earnings Call Transcript: Key Takeaways
Poonawalla Fincorp demonstrates a structural inflection point, shifting from high-growth experimentation to sustainable profitability driven by margin expansion, AI-led efficiency, and improving credit quality.
Poonawalla Fincorp Other Announcement
Poonawalla Fincorp submitted its Asset Liability Management (ALM) statement for the quarter and half year ended September 30, 2026, pursuant to SEBI regulatory requirements.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.